Quantitative relationships between structure and pharmacokinetics of beta-adrenoceptor blocking agents in man
- PMID: 6150103
- DOI: 10.1007/BF01061721
Quantitative relationships between structure and pharmacokinetics of beta-adrenoceptor blocking agents in man
Abstract
The structure and pharmacokinetics relationship of 14-beta-adrenoceptor antagonists was investigated in humans. Statistically significant linear and parabolic correlations were found to exist between standard and derived mean pharmacokinetic parameters and the apparent octanol/buffer (pH 7.4) partition coefficient of the compounds. The lipophilic/hydrophilic properties were the primary determinants for the pharmacokinetic behavior of the compounds. Most of the pharmacokinetic parameters were also significantly correlated with the plasma protein/plasma water partition coefficient for the compounds. When the values of the pharmacokinetic parameters of the individual compounds were predicted from the regressions on the apparent partition coefficients in octanol/buffer (pH 7.4) and in plasma protein/plasma water, the error was on average 60%.
Similar articles
-
Quantitative structure-activity studies of beta-adrenoceptor blocking drugs to decrease ventricular arrhythmias in guinea pigs.Arzneimittelforschung. 1988 Dec;38(12):1796-9. Arzneimittelforschung. 1988. PMID: 2907727
-
Pharmacokinetics of beta-adrenoceptor blockers in obese and normal volunteers.Br J Clin Pharmacol. 1997 Jun;43(6):563-70. doi: 10.1046/j.1365-2125.1997.00609.x. Br J Clin Pharmacol. 1997. PMID: 9205815 Free PMC article. Clinical Trial.
-
Relationships between octanol-water partition data, chromatographic indices and their dependence on pH in a set of beta-adrenoceptor blocking agents.Farmaco. 1990 Jun;45(6):647-63. Farmaco. 1990. PMID: 1980191
-
Pharmacokinetics of beta-adrenoceptor blocking agents: clinical significance of hepatic and/or renal clearance.Clin Physiol Biochem. 1990;8 Suppl 2:28-34. Clin Physiol Biochem. 1990. PMID: 1982759 Review.
-
Clinical consequences of the lipophilicity and plasma protein binding of antiarrhythmic drugs and active metabolites in man.Ann N Y Acad Sci. 1984;432:45-56. doi: 10.1111/j.1749-6632.1984.tb14507.x. Ann N Y Acad Sci. 1984. PMID: 6151820 Review.
Cited by
-
Pharmacokinetic parameters of bevantolol in volunteers.Eur J Clin Pharmacol. 1986;30(3):375-7. doi: 10.1007/BF00541549. Eur J Clin Pharmacol. 1986. PMID: 2874033
-
Clinical pharmacokinetics of beta-adrenoceptor antagonists. An update.Clin Pharmacokinet. 1987 May;12(5):305-20. doi: 10.2165/00003088-198712050-00001. Clin Pharmacokinet. 1987. PMID: 2886244 Review.
-
Charge and lipophilicity govern the pharmacokinetics of glycopeptide antibiotics.Antimicrob Agents Chemother. 1986 Mar;29(3):440-4. doi: 10.1128/AAC.29.3.440. Antimicrob Agents Chemother. 1986. PMID: 2940973 Free PMC article.
-
Saturable pharmacokinetics in the renal excretion of drugs.Clin Pharmacokinet. 1989 Jan;16(1):38-54. doi: 10.2165/00003088-198916010-00003. Clin Pharmacokinet. 1989. PMID: 2650954 Review.
-
Penbutolol: pharmacokinetics, effect on exercise tachycardia, and in vitro inhibition of radioligand binding.Eur J Clin Pharmacol. 1988;35(6):613-23. doi: 10.1007/BF00637597. Eur J Clin Pharmacol. 1988. PMID: 2906875